Literature DB >> 15889361

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration.

Raoul Herbrecht, Yasmine Nivoix.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15889361     DOI: 10.1086/429926

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  19 in total

1.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

2.  Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.

Authors:  Benoît Foligné; Joëlle Dewulf; Pascal Vandekerckove; Georges Pignède; Bruno Pot
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

3.  Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications.

Authors:  R K Rao; G Samak
Journal:  Curr Nutr Food Sci       Date:  2013-05-01

4.  Probiotics for Prevention of Clostridium difficile Infection in Hospitalized Patients: Is the Jury Still Out?

Authors:  Krishna Rao; Vincent B Young
Journal:  Gastroenterology       Date:  2017-04-28       Impact factor: 22.682

Review 5.  Baker's Yeast Clinical Isolates Provide a Model for How Pathogenic Yeasts Adapt to Stress.

Authors:  Vandana Raghavan; Charles F Aquadro; Eric Alani
Journal:  Trends Genet       Date:  2019-09-13       Impact factor: 11.639

6.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; H Bijie; D Dzierzanowska; N N Klimko; V Letscher-Bru; M Lisalova; K Muehlethaler; C Rennison; M Zaidi
Journal:  J Clin Microbiol       Date:  2008-11-12       Impact factor: 5.948

7.  Transcriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strains.

Authors:  Silvia Llopis; Amparo Querol; Antje Heyken; Bernhard Hube; Lene Jespersen; M Teresa Fernández-Espinar; Roberto Pérez-Torrado
Journal:  BMC Genomics       Date:  2012-08-23       Impact factor: 3.969

8.  The gut is the epicentre of antibiotic resistance.

Authors:  Jean Carlet
Journal:  Antimicrob Resist Infect Control       Date:  2012-11-27       Impact factor: 4.887

9.  Pathogenic potential of Saccharomyces strains isolated from dietary supplements.

Authors:  Silvia Llopis; Carolina Hernández-Haro; Lucía Monteoliva; Amparo Querol; María Molina; María T Fernández-Espinar
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

Review 10.  Opportunistic Strains of Saccharomyces cerevisiae: A Potential Risk Sold in Food Products.

Authors:  Roberto Pérez-Torrado; Amparo Querol
Journal:  Front Microbiol       Date:  2016-01-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.